Sign Up for Email Alerts Visit us on Twitter Visit us on Facebook Visit us on YouTube Subscribe to RSS Feeds

Home > In The Spotlight

In The Spotlight

Change Text Size:   Smaller Text Size   Larger Text Size   Default Text Size    

New toolkit -- Solving the physician shortage

A shortage of more than 90,000 physicians is predicted to occur within the next 10 years—including 45,000 primary care physicians and 46,000 surgeons and specialists.

This toolkit, written by Beeta Rasouli of the Alliance, provides links to an array of resources describing numerous challenges to assuring an adequate physician workforce and some proposed solutions. Includes concise background, experts with contact information, and helpful websites. Supported by the Robert Wood Johnson Foundation.

To download, click here.


Toolkit: Emergency Preparedness in the U.S.: The Ebola Threat

Is the U.S. prepared for a potential virulent pandemic? This new Alliance toolkit examines public health infrastructure, funding and policy levers that deal with these kinds of health crises in America.

Read More 

Mike Leavitt Video: Consolidation and Control-The Evolving Health Care System

Mike Leavitt, chairman of Leavitt Partners and former HHS secretary, addresses the aggressive repositioning of players in the evolving health care system in a new Alliance for Health Reform video.

Read More 

Telemedicine Toolkit: The Promise and Challenges

The integration of technology and health care is on the rise. Although evidence shows that telemedicine has improved access to health care and resulted in lower costs in rural and underserved areas, challenges to expansion include reimbursement policies and acceptable security measures. A new Alliance for Health Reform Toolkit, “Telemedicine: The Promise and Challenges,” addresses the effectiveness of telemedicine as a tool for communication, as well as the expected outcomes and challenges ahead.

Read More 

Toolkit on Long-Term Services and Supports (LTSS)

The aging of the baby boomers and the increase in the number of old-old persons (those 85 and older) are predictors for the increasing need for long-term services and supports (LTSS). Among persons age 65 and over, an estimated 70 percent will use LTSS. A new Alliance for Health Reform toolkit, “Long-Term Services and Supports: Changes and Challenges in Financing and Delivery,” provides a background on LTSS and discusses policy issues surrounding the topic.

Read More 

Experts Discuss Workplace Wellness Programs

In a new interview video, Karen Pollitz, senior fellow, private insurance and health reforms, The Kaiser Family Foundation and Dan Newton, vice president, product/solutions development and behavior economics, Anthem Care Management discuss the impact of workplace wellness programs. They address questions about regulations and program design and analyze the scope of wellness programs.

Read More 

Alliance Search for New CEO

WASHINGTON, DC (Aug. 3) – Edward F. Howard, founding executive vice president and CEO of the Alliance for Health Reform in Washington, DC, will retire in March 2016. A nationwide search is underway for his successor.

Over the years, the Alliance has presented hundreds of seminars on Capitol Hill and elsewhere, has organized briefings for reporters around the country and has prepared dozens of issue briefs and “toolkits,” as well as a series of highly-regarded sourcebooks for reporters on health policy topics.

Dr. Robert Graham, Chairman of the Board, noted that the search for a new CEO is being coordinated by Association Strategies of Alexandria, Va. Those interested in learning more about this opportunity should email or call 703/ 683-0580. You can also view the position profile on their website. The deadline for applications is Monday, October 12. 

Read More
Position Profile

Read More 

Toolkit on Biosimilars

The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”

The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.

Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.

Read More 

Copyright 1997-2015 Alliance for Health Reform
1444 Eye Street, NW, Suite 910 Washington, DC 20005-6573      202-789-2300      202-789-2233 fax      Sitemap